Biography

Dayoung Oh, Ph.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Touchstone Diabetes Center

Originally from South Korea, Dr. Oh holds a doctoral degree in molecular endocrinology. She completed her postdoctoral training at Korea University in the laboratory of Jae Young Seong, M.D., and then at the University of California-San Diego in the laboratory of Jerrold Olefsky, M.D.

Dr. Oh joined the UT Southwestern Faculty in 2016.

Dr. Oh's research has focused on the diverse signaling pathways of G protein-coupled receptors (GPCRs) and ligand identification for orphan GPCRs using a high throughput system. As a result, she has developed a particular interest in the role of GPCRs in the fields of obesity, inflammation, and type 2 diabetes. Her group has had a sharp focus on the role of the omega-3 fatty acid receptor, GPR120 in macrophage-mediated chronic inflammation and insulin resistance. Her major focus is the molecular mechanism and signal transduction of GPCRs including GPR120 in various metabolic syndromes. She uses various biochemical and physiological approaches, including using GPCR KO animals (global and tissue-specific), molecular biology, nucleic acid/protein biochemistry, and eukaryotic cell-based studies. Her long-term goal is not only to elucidate how GPCRs work in regulating metabolism but also to identify new avenues for developing therapeutics to treat metabolic syndrome.

Dr. Oh's investigations have resulted in numerous publications in peer-reviewed journals and book chapters, and she has presented her findings at scientific conferences throughout the United States and around the world. In addition, she holds five patents in the U.S. and South Korea.

At UT Southwestern, Dr. Oh teaches in the Graduate School of Biomedical Sciences, and has served on qualifying exam committees and the curriculum committee for the Molecular Metabolism and Metabolic Diseases Program.

Dr. Oh is active in several professional societies, including the Endocrine Society, the American Heart Association, Women in Endocrinology, and the American Diabetes Association.

Education

Graduate School
Chonnam National University (2005), Molecular Biology

Research Interest

  • Chronic Inflammation
  • Development of Novel Therapeutic Targets to Treat Metabolic Syndrome
  • G Protein-Coupled Receptors
  • Insulin Resistance
  • Type 2 Diabetes

Publications

Featured Publications LegendFeatured Publications

GPR84-mediated signal transduction effects metabolic function by promoting brown adipocyte activity.
Sun X, An YA, Paschoal VA, De Souza CO, Wang MY, Vishvanath L, Bueno LM, Cobb AS, Nieto Carrion JA, Ibe ME, Li C, Kidd HA, Chen S, Li W, Gupta RK, Oh DY, J Clin Invest 2023 Oct
Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle.
Peng J, Yu L, Huang L, Paschoal VA, Chu H, de Souza CO, Varre JV, Oh DY, Kohler JJ, Xiao X, Xu L, Holland WL, Shaul PW, Mineo C, Mol Metab 2023 Sep 101812
Adipose tissue macrophages exert systemic metabolic control by manipulating local iron concentrations.
Joffin N, Gliniak CM, Funcke JB, Paschoal VA, Crewe C, Chen S, Gordillo R, Kusminski CM, Oh DY, Geldenhuys WJ, Scherer PE, Nat Metab 2022 Nov 4 11 1474-1494
GPR92 activation in islet macrophages controls ? cell function in a diet-induced obesity model.
de Souza CO, Paschoal VA, Sun XN, Vishvanath L, Zhang Q, Shao M, Onodera T, Chen S, Joffin N, Bueno LM, Gupta RK, Oh DY, J Clin Invest 2022 Sep

Honors & Awards

  • Young Investigator Award
    Women in Endocrinology (2015)
  • AHA Scientist Development Grant
    American Heart Association (2014-2018)

Professional Associations/Affiliations

  • American Diabetes Association (2016)
  • American Heart Association (2014)
  • Endocrine Society (2010)
  • Women in Endocrinology (2014)